279 related articles for article (PubMed ID: 32735933)
21. PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy.
Wang F; Yuan J; Zhang Q; Yang S; Jiang S; Huang C
J Biomater Sci Polym Ed; 2018 Sep; 29(13):1566-1578. PubMed ID: 29749303
[TBL] [Abstract][Full Text] [Related]
22. Fabrication of biocompatible magnetic maltose/MIL-88 metal-organic frameworks decorated with folic acid-chitosan for targeted and pH-responsive controlled release of doxorubicin.
Karimi S; Namazi H
Int J Pharm; 2023 Mar; 634():122675. PubMed ID: 36736967
[TBL] [Abstract][Full Text] [Related]
23. Carbon Dots Embedded Magnetic Nanoparticles @Chitosan @Metal Organic Framework as a Nanoprobe for pH Sensitive Targeted Anticancer Drug Delivery.
Chowdhuri AR; Singh T; Ghosh SK; Sahu SK
ACS Appl Mater Interfaces; 2016 Jul; 8(26):16573-83. PubMed ID: 27305490
[TBL] [Abstract][Full Text] [Related]
24. A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide.
Irani M; Mir Mohamad Sadeghi G; Haririan I
Int J Biol Macromol; 2017 Apr; 97():744-751. PubMed ID: 28109815
[TBL] [Abstract][Full Text] [Related]
25. Biocompatible Zr-based nanoscale MOFs coated with modified poly(ε-caprolactone) as anticancer drug carriers.
Filippousi M; Turner S; Leus K; Siafaka PI; Tseligka ED; Vandichel M; Nanaki SG; Vizirianakis IS; Bikiaris DN; Van Der Voort P; Van Tendeloo G
Int J Pharm; 2016 Jul; 509(1-2):208-218. PubMed ID: 27235556
[TBL] [Abstract][Full Text] [Related]
26. Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells.
Jiang J; Liu Y; Wu C; Qiu Y; Xu X; Lv H; Bai A; Liu X
Drug Dev Ind Pharm; 2017 Aug; 43(8):1304-1313. PubMed ID: 28402175
[TBL] [Abstract][Full Text] [Related]
27. Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier.
Chen G; Luo J; Cai M; Qin L; Wang Y; Gao L; Huang P; Yu Y; Ding Y; Dong X; Yin X; Ni J
Molecules; 2019 Sep; 24(18):. PubMed ID: 31527488
[TBL] [Abstract][Full Text] [Related]
28.
Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458
[TBL] [Abstract][Full Text] [Related]
29. Advanced cardiovascular stent coated with nanofiber.
Oh B; Lee CH
Mol Pharm; 2013 Dec; 10(12):4432-42. PubMed ID: 24050259
[TBL] [Abstract][Full Text] [Related]
30. Novel "Carrier-Free" Nanofiber Codelivery Systems with the Synergistic Antitumor Effect of Paclitaxel and Tetrandrine through the Enhancement of Mitochondrial Apoptosis.
Li X; Yu N; Li J; Bai J; Ding D; Tang Q; Xu H
ACS Appl Mater Interfaces; 2020 Mar; 12(9):10096-10106. PubMed ID: 32027119
[TBL] [Abstract][Full Text] [Related]
31. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
32. Facile preparation of metal-organic frameworks-based hydrophobic anticancer drug delivery nanoplatform for targeted and enhanced cancer treatment.
Dong K; Zhang Y; Zhang L; Wang Z; Ren J; Qu X
Talanta; 2019 Mar; 194():703-708. PubMed ID: 30609594
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
Kefayat A; Vaezifar S
Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043
[TBL] [Abstract][Full Text] [Related]
34. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.
Abouelmagd SA; Ku YJ; Yeo Y
J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous linear release of folic acid and doxorubicin from ethyl cellulose/chitosan/g-C
Nouri A; Faraji Dizaji B; Kianinejad N; Jafari Rad A; Rahimi S; Irani M; Sharifian Jazi F
J Biomed Mater Res A; 2021 Jun; 109(6):903-914. PubMed ID: 32776414
[TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization of PLGA/chitosan nanoparticles as a delivery system for controlled release of DHA.
Liu E; Zhao S; Li X; Meng X; Liu B
Int J Biol Macromol; 2021 Aug; 185():782-791. PubMed ID: 34216672
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of surfactant-modified ZIF-8 with controllable microstructures and their drug loading and sustained release behaviour.
Xu X; Liu Y; Guo Z; Song XZ; Qi X; Dai Z; Tan Z
IET Nanobiotechnol; 2020 Sep; 14(7):595-601. PubMed ID: 33010135
[TBL] [Abstract][Full Text] [Related]
38. Fabrication of functional hollow microspheres constructed from MOF shells: Promising drug delivery systems with high loading capacity and targeted transport.
Gao X; Hai X; Baigude H; Guan W; Liu Z
Sci Rep; 2016 Nov; 6():37705. PubMed ID: 27876876
[TBL] [Abstract][Full Text] [Related]
39. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
40. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
Yang B; Shen M; Liu J; Ren F
Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
